CN109303116A - Red goosefoot breast augmentation nutrition milk shake - Google Patents
Red goosefoot breast augmentation nutrition milk shake Download PDFInfo
- Publication number
- CN109303116A CN109303116A CN201811165476.5A CN201811165476A CN109303116A CN 109303116 A CN109303116 A CN 109303116A CN 201811165476 A CN201811165476 A CN 201811165476A CN 109303116 A CN109303116 A CN 109303116A
- Authority
- CN
- China
- Prior art keywords
- breast augmentation
- breast
- kilograms
- red goosefoot
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000481 breast Anatomy 0.000 title claims abstract description 63
- 230000003416 augmentation Effects 0.000 title claims abstract description 48
- 244000300310 Chenopodium rubrum Species 0.000 title claims abstract description 20
- 235000009332 Chenopodium rubrum Nutrition 0.000 title claims abstract description 20
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 12
- 230000035764 nutrition Effects 0.000 title claims abstract description 9
- 235000020166 milkshake Nutrition 0.000 title claims abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002773 nucleotide Substances 0.000 claims abstract description 24
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 24
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 17
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 17
- 241000209140 Triticum Species 0.000 claims abstract description 17
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 17
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 17
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 17
- 235000021307 Triticum Nutrition 0.000 claims abstract description 16
- 241000894006 Bacteria Species 0.000 claims abstract description 12
- 239000004310 lactic acid Substances 0.000 claims abstract description 12
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 12
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 10
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 10
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000005642 Oleic acid Substances 0.000 claims abstract description 10
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims abstract description 10
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000013336 milk Nutrition 0.000 claims abstract description 10
- 239000008267 milk Substances 0.000 claims abstract description 10
- 210000004080 milk Anatomy 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract description 7
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims abstract description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 238000012797 qualification Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 230000002124 endocrine Effects 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000006210 lotion Substances 0.000 abstract description 4
- 230000001151 other effect Effects 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 206010006187 Breast cancer Diseases 0.000 abstract description 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 235000001497 healthy food Nutrition 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 29
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 25
- 230000006870 function Effects 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 15
- 229910052742 iron Inorganic materials 0.000 description 14
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 9
- 230000036737 immune function Effects 0.000 description 9
- 239000005556 hormone Substances 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 210000005229 liver cell Anatomy 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 230000035790 physiological processes and functions Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000762 glandular Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- -1 iron ion Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010051131 Mastoptosis Diseases 0.000 description 3
- 206010039966 Senile dementia Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000011790 ferrous sulphate Substances 0.000 description 3
- 235000003891 ferrous sulphate Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000871189 Chenopodiaceae Species 0.000 description 2
- 240000006162 Chenopodium quinoa Species 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000008176 mammary development Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010006179 Breast atrophy Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000134336 Malus baccata Species 0.000 description 1
- 235000005079 Malus baccata Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033122 Ovarian atrophy Diseases 0.000 description 1
- 241000751898 Paederus fuscipes Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000025844 Prostatic disease Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000008195 breast development Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000033822 gland development Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000023247 mammary gland development Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 231100001043 ovarian atrophy Toxicity 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2240/00—Use or particular additives or ingredients
- A23C2240/15—Use of plant extracts, including purified and isolated derivatives thereof, as ingredient in dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Red goosefoot breast augmentation nutrition milk shake belongs to high-end plant healthy food, especially with raw materials such as Qinghai-Tibet natural pollution-free green high quality red goosefoot wheat extract (milk), nucleotide, bis- oleic acid 2- palmitic acid of 1.3-, three rouge, lactoferrin, breast augmentation ferment, lactic acid bacterias, which has nourishing liver and kidney, nourishing yin and nourishing blood, benefiting shrewd head, strengthening spleen and nourishing stomach, strengthen immunity, anti-oxidant, breast augmentation, anti-breast cancer, crease-resistant, beautifying face and moistering lotion, improves microcirculation, adjusts endocrine, anti-aging, cancer-resisting and other effects.
Description
One, technical field: the invention belongs to high-end plant function solid beverages, especially with Qinghai-Tibet natural pollution-free green
The raw materials such as organic high-quality red goosefoot wheat extract (milk), the solid beverage being process using modern most advanced technique.
Two, background technique: the invention is with pure natural medical and edible dual purpose plant red goosefoot wheat extract (milk), nucleotide, 1.3-
Nutrition breast augmentation product made of the raw materials such as two oleic acid 2- palmitic acids, three rouge, lactoferrin, breast augmentation ferment, lactic acid bacteria, auxiliary material.
The product is in strengthen immunity, anti-oxidant, breast augmentation, anti-breast cancer, crease-resistant, beautifying face and moistering lotion, improvement microcirculation, adjusting points
It secretes, delay senescence, cancer-resisting and other effects.Currently on the market there are no similar product, the product, purity is high, life are researched and developed in innovation
Object activity is strong, is absorbed and utilized, is without any side effects, is convenient to take, significant effect.Adolescence for congenital micromazia
Maiden has crossed puberty and the mastoptosis due to caused by childbirth and lactation, loose, atrophy the young and the middle aged and postmenopausal women
Breast augmentation is taken.
Three, summary of the invention: for women, beautiful skin, tall and straight plentiful breast, moving curve are modern female
People is expected the dream asked.With the economic fast continual development in China, the continuous improvement of national income and levels of substance,
Huge variation has occurred to beautiful and health pursuit in people, and especially women enantiomorph U.S. is stronger, especially crosses
The women in puberty and child-bearing period, due to ovarian atrophy and deterioration, organism endocrine balance is changed, estrogen point
Reduction is secreted, gradually atrophy is sagging for breast, and dry skin such as follows the string at the symptoms.There are also honest adolescence because of mammogenesis not
Good, breast is flat without self-confident maiden, and innovates and research and develop a kind of breast-enlarging and beautifying functions new product.
Four, composition of raw materials: 50-100 kilograms of extract (milk), 3-7 kilograms of nucleotide, bis- oleic acid 2- palmitinic acid of 1.3- are sweet
Oily 2-8 kilograms of three rouge, 2-6 kilograms of lactoferrin, 5-10 kilograms of breast augmentation ferment, 1-5 kilograms of lactic acid bacteria, auxiliary material are raw material.
Five, technical solution
(1), South America Chenopodiaceae, Kui Mai, golden millet etc. red goosefoot wheat: are called.America andes region is originated in, is print plus original inhabitants
The main conventional food of resident has brought up print plus nationality due to enriching comprehensive nutritive value with uniqueness, referred to as grain it
Mother, can also be edible instead of baby milk powder.The areas such as China Qinghai were introduced in recent years and plant experimentally success, in Qinghai-Tibet height above sea level
2800 or more Caidamu Basin large area plantation.The mature seed of the sub- red goosefoot wheat of red goosefoot wheat category Chenopodiaceae undergraduate course double leaf.It is sweet natured,
With general equilibrium extra-nutrition, there is enhancing body function and enhance immune function, reparation constitution, raising organism adaptation ability,
It adjusts endocrine, breast augmentation, promote upgrowth and development of children, prevention disease, beautifying face and moistering lotion, weight-reducing, defaecation, anti-aging, anti-cancer anti-
Cancer, lowering blood pressure and blood fat, hypoglycemic, prevention and treatment cardiovascular and cerebrovascular disease, adjuvant treatment chronic disease and other effects and pregnant and lying-in women
Super nutritive food thinks that red goosefoot wheat is that only monomer plant had both met human body basic nutrition demand by FAO (Food and Agriculture Organization of the United Nation)
Food, recommendation red goosefoot wheat are the perfect nutraceutical of the optimum mankind, are listed as " the super cereal " of global 10 big health-nutritions,
" the following food ", to promote the health of the mankind.It is specially adapted to hypertension, hyperlipidemia, hyperglycemia, cardiovascular and cerebrovascular disease, and
Significant effect is eaten for a long time in the crowds such as the special constitution such as infant, pregnant and lying-in women, children, the elderly.
Nutritional ingredient: red goosefoot wheat protein rich in (up to 26%, and quality is suitable with milk powder and Beef), carbon
Hydrate, a variety of amino acid, wherein contains all 9 kinds of amino acid needed by human at fat, and ratio is appropriate and easily absorbs, and goes back
Rich in unsaturated fatty acid, flavonoids, beta glucan, choline, glycine betaine, alpha-linolenic acid, mineral calcium, magnesium, phosphorus, potassium, iron,
Zinc, selenium, manganese, copper etc., the compounds such as vitamin B complex, folic acid, vitamin E, dietary fiber content are up to 7.1%, solid without gallbladder
Alcohol.
Physiological function: 1, enhance immune function: the study found that red goosefoot wheat has enhancing body disease prevention and disease resistance, adjusting
The effect of body's immunity, wherein protein abundant is the main component for constituting blood red ball and antibody in quinoa.Experiment card
Bright, there is a serious shortage of the lymph corpuscles that can make in the immunocyte of people to subtract greatly, causes serious immunity function to decline, and easy infection disease
Disease.In addition, having extremely strong effect to body immune system containing β-glucose in red goosefoot wheat, have the function of activating cell, prevents
Only body is infected and repairs the tissue being destroyed, meanwhile, there are also active cells for β-glucose in red goosefoot wheat, improve immune function
Effect.And nutriment balanced in quinoa can also improve immunity by improving constitution.
2, endocrine is adjusted: studies have shown that red goosefoot wheat, which has, adjusts endocrine effect.Red goosefoot wheat extract can promote kidney
Upper gland cortex hormone function and the adrenal weight of increase, increase Thyroxine Contents in blood, and therefore, red goosefoot wheat is adjustable interior point
It secretes.
3, breast augmentation: again whether development and body hormone secretion itself have a very big relationship to female chest, under hormonal readiness
Drop will lead to breast tissue cell reduce and breast it is soft it is sagging, collapse, eventually lead to mastatrophy.One recent studies on discovery,
With function of breast augmentation, has the function of similar estrogen containing abundant flavonoids, can effectively adjust female incretion has well
Breast augmentation effect.The good protein being rich in can prevent breast relaxation and sagging.In addition the fat that contains, sugar, dietary fiber, more
The effect of nutritional ingredients such as kind vitamin and mineral not only have apparent function of breast augmentation, but also there are also U.S. chests.
(2), nucleotide: also known as nucleotide is ribose and deoxyribose and tricresyl phosphate kind by purine base or pyrimidine base
The compound of material composition.There are ribonucleotide, two class of deoxynucleotide according to the different nucleotide of sugar.Nucleotide is ribose core
The composition unit of acid and DNA, is the precursor substance of internal nucleic acid.Nucleotide is distributed organism with nucleic acid
Interior each organ is organized, and in nucleus and cytoplasm, and biological heredity is participated in as the constituent of nucleic acid, development, growth etc.
Basic vital movement.Nucleotide is primarily involved in composition nucleic acid, and many mononucleotides also have a variety of important biological functions, such as
Atriphos (ATP) related with energetic supersession, codehydrogenase etc., the similar substance of certain nucleotide, energy interfering nucleic acid
Metabolism, can be used as anticancer drug.Be a kind of guarantor's youth nutriment have delay senescence, enhancing immune function, anti-mutation, prevention and treatment
Cancer, the damage of anti-chemicotherapy, antiviral, prevention and treatment hepatopathy, anti-radiation, antifatigue, adjusting endocrine, breast augmentation, anti-oxidant, the prevention and treatment heart
Vascular diseases and senile dementia, raising memory, beautifying face and moistering lotion and other effects.
Physiological function: 1, liver protection: the study found that nucleotide pair protect liver cell, promote DNA synthesis and liver cell repair with
And protein synthesis has apparent curative effect.Also there are obvious anti-liver cell Fibrosis parameters, it is hard to improvement chronic hepatitis and liver
The protein metabolism of change also has certain curative effect.
2, adjust endocrine: nucleotide can make lower blood brain-hypophysis-gonad function balance metabolism, thus can alleviate sex character and move back
Change and the various degradation symptoms such as sexual organ atrophy.Zoopery is shown, after mouse oral takes nucleotide, can make ovary and testis
The weight of ball increases, and can release spirit and psychological imbalance.
3, antifatigue: the study found that eating the increase of hemoglobin and affinity for oxygen after nucleotide, to be conducive to supply brain
Tissue, cell oxygen carrying content increase, thus eliminate brain because for hypoxgia and lack nutrition caused by fatigue.
4, enhance immune function: nucleotide improves cell viability, improves body group by participating in cell metabolism and update
It knits, itself function and Self-adjustment ability of organ and system, realizes the physiological equilibrium of best comprehensive state, it is immune to reach raising
Function is built up health.A large amount of research and clinical testing data prove that nucleotide has the immune function that is significantly improved, activation
Immune system, resistance building restore intestinal physiology function, perfect intestinal immunological barrier, extraneous nucleotide is to maintenance siberian crabapple
Normal function of uniting has obvious action.
5, promote the development of breast diauxic growth: nucleotide has good breast augmentation to act on.One recent studies on discovery, nucleotide are
Mammary glandular cell basis all plays very important effect to organism organ growth, development, breeding, heredity etc., " very
Claim flowers of life ".Studies have shown that nucleotide can be such that Hypothalamus-Pituitary-Gonad functional metabolism balances, promote hormone secretion, and swashs
Element is a kind of proteohormone indispensable in female breast growth and development process, is secreted by pituitary gland sexual gland, master control cream
Gland development, promotes new mammary glandular cell growth and development, improves breast tissue nutrition, develops mammary glandular cell diauxic growth.Therefore,
Nucleotide can be such that female breast increases, plentiful, tall and straight.In addition, nucleotide can also prevent other than with good breast augmentation effect
The effects of mastoptosis.
(3), bis- oleic acid 2- palmitic acid of 1.3-, three rouge (opo), bis- oleic acid 2- palmitic acid of 1.3-, three rouge are to exist
In one of cow's milk fat structural fatty acid, there is the triglyceride of special fatty acid the Nomenclature Composition and Structure of Complexes, has a variety of physiology living
Sexual function.
Physiological function: 1, breast augmentation: bis- oleic acid 2- palmitic acid of 1.3-, three rouge can promote human body preferably to absorb nutrients
Matter and fat are developed chest again and are had very important effect.One recent studies on discovery, bis- oleic acid 2- palmitinic acid of 1.3- are sweet
Bis- oleic acid 2- palmitic acid of 1.3-, three rouge can be transported to chest in conjunction with mammary glandular cell and be increased by blood circulation by oily three rouge
Butter oil tissue elasticity, moreover it is possible to promote female sex hormone to secrete, have a significant effect to promotion mammary gland secondary development, and can also
Effectively play the sagging effect of prevention breast deformation.
(4), lactoferrin: being a kind of glycoprotein for being combined with iron there are in cow's milk.Nineteen sixty is by foreign scholar from ox
It separates and obtains in cream, have very close relationship with the transferrins that can transmit iron ion in blood glucose.The master of lactoferrin molecules
Body is the single chain polypeptide that a relative molecular mass is about 80000, and connects 1-2 glycocide.Tool modern medicine study proves, newborn
Ferritin has a variety of biological functions.
Chemical component: containing the glycosyls such as lactose, mannose and polypeptide in conjunction with there are two molecules in lactoferrin molecules
Peptide.
Physiological function: 1, promote iron to absorb: lactoferrin has high affinity to iron ion, is a kind of ideal iron load
Body can increase the biological utilisation of iron to promote the absorption to iron.Because lactoferrin can in conjunction with iron after be transported to the spy of enteron aisle
Tapping is discharged again after very receiving cell so that body absorbs.Someone once tested mouse, compared ferrous sulfate and newborn iron egg
White effect, as a result, it has been found that, such as often reaching 200mg with the every consumption per day of ferrous sulfate merely can be such that hemoglobin realizes normally, such as
Add and use lactoferrin, then only needing 50mg i.e. can reach normally, and only almost not worked with 50mg ferrous sulfate person.
2, enhance immunoloregulation function: research has shown that, orally authorizes the activity of natural kill (NK) cell of spleen cell
It significantly rises, in neutrocyte, the various immunocyte surfaces such as monocyte/microphage, lymphocyte have newborn iron
The recipient of albumen.Therefore, when the lactoferrin in serum containing 0.3-0.5mg/ml, so that it may lead to releasing for neutral cell
It puts.In the case where nonspecific infection, the yield of the neutral cell induced by lactoferrin is 6 times usually, burst size
Then increase by 20 times.To the various immunoregulation effects of lactoferrin, either in vivo or in test tube, confirm there is significant promotion
Phagocytosis and the killing effect of neutral cell or microphage, promote the activation of natural killer cells, in lymphocyte
Property leucocyte proliferation adjust the effects of.
3, anti-oxidant: lactoferrin has the ability for combining and shifting free iron and bivalent metal ion, therefore can inhibit gold
Belong to the oxidation process that ion plays catalytic action, inhibits the formation of the free radical of peroxide.
4, breast augmentation: a recent studies on shows that female breast development is bad, and unobvious with secondary sex characters is because in women body
Caused by secreting the factors such as function disorder imbalance, and a lactoferrin new function therein has adjusting female incretion, makes body
Estrogen hormone level increases, to promote breast to grow, so that reaching makes busty purpose.In addition, in lactoferrin
Breast can also be made tall and straight plentiful rich in nutriments such as iron ions.
(5), breast augmentation ferment (Enzyme) is a kind of substance with special bioactivity being made of amino acid, is structure
At the special protein of one kind necessary to bio-tissue, breast augmentation ferment is the general name of various enzymes.The breast augmentation ferment being currently known
About more than 2000 kinds of element participates in the duplication of gene, the reparation of DNA, recombination, transfer and dimension in each activity of human life
Hold Telomere Stability.Human body lacks breast augmentation ferment, and 5 big nutrition (carbohydrate, proteins,vitamins,minerals, lipid) all will
Become to body generate adverse effect, breed chronic disease, as hypertension, hyperlipidemia, coronary heart disease, diabetes and vascular diseases,
Artery sclerosis, cerebral thrombosis, apoplexy, arthritis, gastroenteritis, prostatic disorders, fatiguability, failure of memory, senile dementia, tumour
Deng.Supplement breast augmentation ferment can promote the absorption of human body gastrointestinal disturbances, improves sleep quality, reduces blood viscosity, is weight-reducing, soft
Change blood vessel, Dealcoholic sobering-up, skin maintenance and cosmetic benefits, eliminate chloasma, prevention and treatment osteoporosis and a variety of chronic diseases, promotes health
Function.
Physiological function: 1, protect liver: breast augmentation enzyme granule has Liver Damage in Rats caused by carbon tetrachloride to mouse stomach-filling
Significant protective effect can reduce liver cell fatty lesion and necrosis of liver cells, prevent swelling of liver cell, and liver cell is promoted to repair
It is multiple, and the effect for reducing the glutamic-pyruvic transaminase in serum also.
2, anti-oxidant: breast augmentation ferment has significant anti-oxidation function, it can block rapidly free radical to participate in oxidation reaction
With the formation of oxygen radical, extra free radical is removed, reduces and prevents that oxidative damage occurs in human body, keep interior free yl
Equilibrium state reaches oxidation resistant purpose with this.
3, catharsis and toxin expelling: breast augmentation ferment has very strong catharsis and toxin expelling effect, studies have shown that fat-soluble toxins ensconce device deeply
Official's is intracellular, is to be very unlikely to exclude, and research has shown that, the one mostly important effect of breast augmentation ferment can start self-healing function machine
System can effectively come out the toxin dissolution of many years in hiding cell in vivo, be used after being burnt, and with excrement
Excrete, further, it is also possible to help digest absorption, shorten the residence time of food in the intestine, inhibit food in enteron aisle into
The generation of row putrefactive fermentation and toxin accelerates intestines peristalsis, promotes defecation, excludes enterotoxin.
4, enhance immune function: the study found that breast augmentation ferment with play an important role in immune response.To breast augmentation ferment
Element, which carries out discovery ferment in immune function test, can improve the activity of T lymphocyte, and can reinforce cell manufacture antibody ability.Separately
It is reported that foreign study found that, breast augmentation ferment can promote T cell to generate Y- interferon, have and resist virus infection, inhibit swollen
Tumor cell growth and adjusting machine stop the effect of immune function.
5, breast augmentation: girl's hormone in vivo level in Paederus fuscipes Curtis period determines mammary development size, and hormone secretion is just
Its normal mammary development will be plentiful.Recent studies on shows that breast augmentation ferment can stimulate estrogen to secrete, this breast augmentation ferment class
Like growth hormone, also known as breast augmentation hormone, this hormone can stimulate female ovary to secrete estrogen, have reached breast secondary development
Purpose, therefore, breast augmentation ferment have the function of breast augmentation.
In addition, breast augmentation ferment also has antibacterial anti-inflammatory, skin maintenance and cosmetic benefits, eliminate chloasma, prevention and treatment cardiovascular and cerebrovascular disease, climacteric
The multiple efficacies such as phase syndrome, premenstrual syndrome, senile dementia, inferior health, arthritis, Dealcoholic sobering-up, anti-aging, anticancer.
(6), lactic acid bacteria (Lactics), lactic acid bacteria are to utilize carbohydrate as energy, generation by fermenting
Thank to the general name of a kind of bacterium of the product based on lactic acid.Have the function of a variety of physiology sp acts.
Biological activity function: 1, chest enlarge: regulator of the lactic acid bacteria as Tiny ecosystem, it can a variety of dimensions needed for synthesized human
The nutritional ingredients such as raw element promote absorption and utilization of the human body to nutriments such as calcium, iron, recent studies have shown that, lactic acid bacteria has
The biological functions such as good chest enlarge.Women's tracing study of lactic acid bacteria is taken by 96, as a result, it has been found that 90% or more former breast
Hypogenetic women, after taking a period of time, chest is more plentiful, and thus lactic acid bacteria has good function of breast augmentation.
In summary: for the product by two groups of control women of the health to 52 ages between 20-60 years old, one group every
It takes addition 50-100g breast augmentation milk shake, and another group is taken ordinary milk daily, after 12 weeks, as a result, it has been found that, take breast augmentation milk shake
One group of female bra increase by 2.5 centimetres, and the female control group for taking ordinary milk does not have significant change, all to say breast augmentation milk
There is good function of breast augmentation in former times.
Seven, quality standard:
1, physical and chemical index:
2, dose: 3 times a day, every 30-50 grams.
3, suitable population: suitable for the adolescent girl of congenital micromazia, puberty has been spent and due to giving a birth and feeding
Mastoptosis caused by cream, loose, atrophy the young and the middle aged and postmenopausal women breast augmentation are taken.
Eight, specific embodiment:
Embodiment: 50-100 kilograms of red goosefoot wheat extract (milk), 3-7 kilograms of nucleotide, bis- oleic acid 2- palm of 1.3- are taken
2-8 kilograms of three rouge of acid glycerol, 2-6 kilograms of lactoferrin, 5-10 kilograms of breast augmentation ferment, 1-5 kilograms of lactic acid bacteria, auxiliary material are raw material.
By mixing the above raw material, stirs, sterilize, examine qualification, packaging becomes finished product.
Claims (1)
1. red goosefoot breast augmentation nutrition milk shake manufacture craft, it is characterized in that: 50-100 kilograms of red goosefoot wheat extract (milk), nucleotide 3-
7 kilograms, bis- 2-8 kilograms of three rouge of oleic acid 2- palmitic acid of 1.3-, 2-6 kilograms of lactoferrin, 5-10 kilograms of breast augmentation ferment, lactic acid
1-5 kilograms of bacterium, auxiliary material are raw material.By mixing the above raw material, stirs, sterilize, examine qualification, be packaged into and be positive
Formula product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811165476.5A CN109303116A (en) | 2018-10-08 | 2018-10-08 | Red goosefoot breast augmentation nutrition milk shake |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811165476.5A CN109303116A (en) | 2018-10-08 | 2018-10-08 | Red goosefoot breast augmentation nutrition milk shake |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109303116A true CN109303116A (en) | 2019-02-05 |
Family
ID=65225117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811165476.5A Pending CN109303116A (en) | 2018-10-08 | 2018-10-08 | Red goosefoot breast augmentation nutrition milk shake |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109303116A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105076425A (en) * | 2015-09-17 | 2015-11-25 | 许德建 | Yak, cow and ewe three-in-one composite infant formula milk powder |
CN105815514A (en) * | 2016-05-18 | 2016-08-03 | 苟春虎 | Weight-losing quinoa milk tea |
CN107156817A (en) * | 2017-05-31 | 2017-09-15 | 苟春虎 | Matrimony vine breast augmentation ferment |
KR20170124067A (en) * | 2016-04-29 | 2017-11-09 | 가천대학교 산학협력단 | Pharmaceutical composition for preventing or treating anticancer drug resistant breast cancers comprising expression or activity inhibitor of SETD1A as an active ingredient |
-
2018
- 2018-10-08 CN CN201811165476.5A patent/CN109303116A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105076425A (en) * | 2015-09-17 | 2015-11-25 | 许德建 | Yak, cow and ewe three-in-one composite infant formula milk powder |
KR20170124067A (en) * | 2016-04-29 | 2017-11-09 | 가천대학교 산학협력단 | Pharmaceutical composition for preventing or treating anticancer drug resistant breast cancers comprising expression or activity inhibitor of SETD1A as an active ingredient |
CN105815514A (en) * | 2016-05-18 | 2016-08-03 | 苟春虎 | Weight-losing quinoa milk tea |
CN107156817A (en) * | 2017-05-31 | 2017-09-15 | 苟春虎 | Matrimony vine breast augmentation ferment |
Non-Patent Citations (1)
Title |
---|
张明: "《好喝易做养生蔬果汁随身查》", 31 July 2013, 天津科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108142803A (en) | Full nutrition coarse food grain | |
CN105795468A (en) | Composition having efficacy of losing weight | |
CN101991019A (en) | Traditional Chinese medicine chicken feed and production method of silky fowl egg capable of tonifying kidney, strengthening yang and resisting fatigue | |
CN105815514A (en) | Weight-losing quinoa milk tea | |
CN105707707A (en) | Super quinoa nutrition powder for pregnant and lying-in women | |
CN106107463A (en) | Super Quinoa Antifatigue milk tea processing technology | |
CN103653170A (en) | Stachyose probiotics solid beverage | |
CN101569410A (en) | Special meal nutritional foods used by tumor patients | |
CN110301629A (en) | A kind of full nutrient solid beverage of tumor patient and preparation method thereof | |
CN102144748A (en) | Five-color flour food with functions of excreting toxins, protecting liver and maintaining beauty | |
CN105341668A (en) | Health-preserving quinoa porridge | |
KR20010072587A (en) | Dietary supplement derived from fermented milks for the prevention of osteoporosis | |
CN103598333A (en) | Yogurt capable of invigorating spleen to promote digestion and processing process thereof | |
CN104738638A (en) | Composition with anti-fatigue effect and application thereof | |
CN103190483A (en) | Children growth promotion milk tea | |
CN102499291B (en) | Milk powder with functions of maintaining beauty and keeping young and improving immunity of organism and preparation method thereof | |
CN105358127A (en) | Petroselinic acid or a combination of active ingredients comprising at least petroselinic acid for promoting weight loss and/or weight maintenance | |
CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
CN103535576B (en) | Meal replacement powder containing pollen | |
CN109170916A (en) | One kind keeps fit and healthy food compositions and preparation method thereof | |
CN102090453A (en) | Weight-reducing and beautifying milk tea | |
CN109303115A (en) | Raw ketone weight losing meal-replacing milk shake | |
CN102511875A (en) | Red jujube thick syrup applicable for postoperation people to drink | |
CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
CN108371709A (en) | Lycium ruthenicum tumor recovering gene enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Gu Chun Hu Document name: Deemed withdrawal notice |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190205 |